期刊文献+

红细胞载药体系研究现状 被引量:7

下载PDF
导出
摘要 红细胞作为药物载体,无需合成,并具有合成药物载体无法比拟的优势。用患者自身的红细胞作为药物的载体,其生物相容性和残体的降解都能得到保证。应用红细胞载药体系进行靶向治疗,被认为是一个极具前途的发展方向。
机构地区 解放军第
出处 《中国医院用药评价与分析》 2011年第10期959-960,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献13

  • 1王宣,钱宝华,查占山,吴江,郭峰.甲氨蝶呤与长春新碱双载红细胞的制备及其生物学特性[J].解放军医学杂志,2006,31(7):670-672. 被引量:3
  • 2Wang GP, Guan YS, Jin XR , et al. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites [ J ]. Gastroenterol Hepatol,2010,25 (5) :985.
  • 3余华,简家荣,李萍,李绍平,王一涛.红细胞载体——一种新颖的药物传输系统[J].中华临床医药杂志(北京),2004,5(8):3-6. 被引量:4
  • 4吴江,钱宝华,王卓,王宣,罗庆峰,牛芳.长春新碱载药红细胞制备及其生物学特性研究[J].第二军医大学学报,2005,26(5):551-554. 被引量:14
  • 5Bodemann H, Passow H. Factors controlling theresealing of themembrane of human eryth rocyte ghostsafter hypotonic hemolysis [ J]. J M embr Bio1,2002,8 ( 1 ) :12.
  • 6Kinosita K Jr,Tsong TY. Formation and resealing of pores of controlled size in human erythrocytemembrane [ J ]. Nature, 1998,268 (5619) :438.
  • 7Schriei SL, Bensch KG, Johnson M, et al. Energized endocytosis in human erythrocyte ghosts [ J ]. J Clin Invest,2004,6( 1 ) :8.
  • 8Meyer HW, Richter W, Winkelmann H. Nystatin and amphotericin induced structural alterations of theerythrocyte membrane : importance of reduced ionicstrength [ J ]. Exp Pathol, 1993,24 ( 223 ) : 163.
  • 9Connor J, Yatvin MB, Huang L. pH-sensitive liposomes : acid-induced liposome fusion [ J ]. Proc Natl Acad Sci USA,2000,81(6) :1715.
  • 10Patel PD, Dand N, Hirlekar RS, et al. Drug loaded erythrocytes: as novel drug delivery system [ J ]. Curr Pharm Des ,2008,14( 1 ) :63.

二级参考文献19

  • 1王宣,钱宝华,郭峰,吴江,蔡志扬,顾海慧.脐血红细胞包载甲氨喋呤的可行性研究[J].深圳中西医结合杂志,2005,15(1):31-33. 被引量:3
  • 2吴江,钱宝华,王卓,王宣,罗庆峰,牛芳.长春新碱载药红细胞制备及其生物学特性研究[J].第二军医大学学报,2005,26(5):551-554. 被引量:14
  • 3吴江,钱宝华,刘书逊,王卓,花美仙,郭峰.长春新碱载体红细胞的体外抗肿瘤作用[J].解放军医学杂志,2005,30(7):593-595. 被引量:11
  • 4郭峰.癌细胞激活血液免疫反应路线图实验体系[J].肿瘤学杂志,2005,11(4):309-311. 被引量:8
  • 5Garin MI,Lopez RM,Sanz S,et al. Erythrocytes as carriers for recombinant human erythropoietin[J]. Pharm Res,1996,13(6):869-874.
  • 6Sanz S,Lizano C,Luque J,et al. In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure[J]. Life Sci,1999,65(26):2781-2789.
  • 7Kravtzoff R,Ropars C,Laguerre M,et al. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies[J]. J Pharm Pharmacol,1990,42(7):473-476.
  • 8O'Byrne KJ,Steward WP. The promise of improved drug delivery[J]. Clin Sci (London),1999, 96(2):127-128.
  • 9Jain S,Jain NK. Preparation,characterization and pharmaceutical potential of engineered erythrocytes[J]. Pharmazie,1998,53(1):5-14.
  • 10Tajerzadeh H,Hamidi M. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes[J]. Drug Dev Ind Pharm,2000,26(12):1247-1257.

共引文献16

同被引文献80

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部